Drug Profile
Asivatrep - Amorepacific
Alternative Names: PAC 14028Latest Information Update: 22 Feb 2022
Price :
$50
*
At a glance
- Originator Amorepacific
- Class Acrylates; Acyclic acids; Amides; Anti-inflammatories; Antipruritics; Pyridines; Skin disorder therapies; Small molecules
- Mechanism of Action TRPV1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis; Pruritus; Rosacea; Seborrhoeic dermatitis; Skin disorders
Most Recent Events
- 22 Feb 2022 Discontinued - Phase-II for Pruritus in South Korea (Topical)
- 22 Feb 2022 Discontinued - Phase-II for Rosacea in South Korea (Topical)
- 22 Feb 2022 Discontinued - Phase-II for Seborrhoeic dermatitis in South Korea (Topical)